EyePoint Pharmaceuticals Files 8-K
Ticker: EYPT · Form: 8-K · Filed: May 7, 2025 · CIK: 1314102
| Field | Detail |
|---|---|
| Company | Eyepoint Pharmaceuticals, Inc. (EYPT) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financials, operations
Related Tickers: EYPT
TL;DR
EYPT filed an 8-K on May 7th covering operations and financials.
AI Summary
EyePoint Pharmaceuticals, Inc. filed an 8-K on May 7, 2025, reporting on its results of operations, other events, and financial statements. The company, formerly known as pSivida Corp. and pSivida LTD, is incorporated in Delaware and headquartered in Watertown, Massachusetts.
Why It Matters
This filing provides an update on EyePoint Pharmaceuticals' operational and financial status, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, providing standard corporate information without immediate material news.
Key Numbers
- 000-51122 — SEC File Number (Identifies the company's filing with the SEC.)
- 26-2774444 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- EyePoint Pharmaceuticals, Inc. (company) — Registrant
- pSivida Corp. (company) — Former company name
- pSivida LTD (company) — Former company name
- May 07, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Watertown, Massachusetts (location) — Principal executive offices location
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates 'Results of Operations and Financial Condition' are being reported, but the specific details are not provided in this excerpt.
What 'Other Events' are being disclosed?
The filing lists 'Other Events' as an item, but the nature of these events is not detailed in the provided text.
When did EyePoint Pharmaceuticals change its name from pSivida Corp.?
The filing states the date of name change from pSivida Corp. was June 19, 2008.
What is the company's principal executive office address?
The principal executive offices are located at 480 Pleasant Street, Suite B300, Watertown, Massachusetts 02472.
What is the SIC code for EyePoint Pharmaceuticals?
The Standard Industrial Classification (SIC) code is 3826, for Laboratory Analytical Instruments.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding EyePoint Pharmaceuticals, Inc. (EYPT).